507 related articles for article (PubMed ID: 19649144)
1. Apolipoprotein E and cholesterol in aging and disease in the brain.
de Chaves EP; Narayanaswami V
Future Lipidol; 2008 Oct; 3(5):505-530. PubMed ID: 19649144
[TBL] [Abstract][Full Text] [Related]
2. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.
Chernick D; Ortiz-Valle S; Jeong A; Qu W; Li L
Neurosci Lett; 2019 Aug; 708():134306. PubMed ID: 31181302
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Poirier J
Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
[TBL] [Abstract][Full Text] [Related]
4. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels.
Jansen PJ; Lütjohann D; Thelen KM; von Bergmann K; van Leuven F; Ramaekers FC; Monique M
J Alzheimers Dis; 2009; 18(2):319-29. PubMed ID: 19584433
[TBL] [Abstract][Full Text] [Related]
5. ApoE and Neurodegenerative Diseases in Aging.
Yin Y; Wang Z
Adv Exp Med Biol; 2018; 1086():77-92. PubMed ID: 30232753
[TBL] [Abstract][Full Text] [Related]
6. Cellular cholesterol homeostasis and Alzheimer's disease.
Chang TY; Yamauchi Y; Hasan MT; Chang C
J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
Chai AB; Lam HHJ; Kockx M; Gelissen IC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
[TBL] [Abstract][Full Text] [Related]
8. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.
Gong JS; Kobayashi M; Hayashi H; Zou K; Sawamura N; Fujita SC; Yanagisawa K; Michikawa M
J Biol Chem; 2002 Aug; 277(33):29919-26. PubMed ID: 12042316
[TBL] [Abstract][Full Text] [Related]
10. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H
Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
13. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
14. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
15. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.
Rawat V; Wang S; Sima J; Bar R; Liraz O; Gundimeda U; Parekh T; Chan J; Johansson JO; Tang C; Chui HC; Harrington MG; Michaelson DM; Yassine HN
J Neurosci; 2019 Nov; 39(48):9611-9622. PubMed ID: 31641056
[TBL] [Abstract][Full Text] [Related]
16. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice.
Jenner AM; Lim WL; Ng MP; Wenk MR; Shui G; Sharman MJ; Gandy SE; Martins RN
Neuroscience; 2010 Aug; 169(1):109-15. PubMed ID: 20416362
[TBL] [Abstract][Full Text] [Related]
17. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
18. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes.
Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD;
Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545
[TBL] [Abstract][Full Text] [Related]
19. APOE and Alzheimer's Disease: From Lipid Transport to Physiopathology and Therapeutics.
Husain MA; Laurent B; Plourde M
Front Neurosci; 2021; 15():630502. PubMed ID: 33679311
[TBL] [Abstract][Full Text] [Related]
20. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
